PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Compensation for Research Injuries: National Regulations and International Standards

Research regulations worldwide aim to prevent research injuries, as well as to provide remedies for injuries suffered by research participants, regardless of what or who may have caused those injuries. The ICH-GCP guidelines mandate that sponsors make provisions for compensation for research-related injuries, but largely leave compliance to applicable national or local regulatory requirements. Chitra Lele and Suhasini Sharma at Sciformix discuss the hotly- debated topic of how and why patients are to be compensated, and how worldwide regulations differ considerably.

https://international-pharma.com/wp-content/uploads/2013/06/5-Compensation-for-Research-Injuries.pdf
 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026